Alpha Cognition Inc. balance sheet
At the end of fiscal 2025, Alpha Cognition Inc. had total assets of $79.7m, total liabilities of $17.2m and shareholders' equity of $62.5m. It held $66.0m in cash against $0 of debt: net cash of $66.0m.
Balance sheet
| Fiscal year | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|
| Cash and equivalents | 66 | 41 |
| Receivables | 4 | 5 |
| Inventory | 5 | 6 |
| Total current assets | 79 | 58 |
| Total assets | 80 | 65 |
| Accounts payable | 3 | 1 |
| Deferred revenue (current) | 0 | 0 |
| Total current liabilities | 9 | 6 |
| Total debt | 0 | 0 |
| Total liabilities | 17 | 12 |
| Shareholders' equity | 63 | 53 |
| Net debt (negative = net cash) | −66 | −41 |
| Shares outstanding | 22m | 22m |
| Quarter | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|
| Receivables | 0 | 2 | 3 | 4 | 4 | 5 |
| Inventory | 1 | 1 | 4 | 5 | 6 | 6 |
| Total current assets | 48 | 45 | 46 | 79 | 69 | 58 |
| Total assets | 49 | 45 | 46 | 80 | 69 | 65 |
| Accounts payable | 1 | 1 | 1 | 3 | 1 | 1 |
| Deferred revenue (current) | 0 | — | — | 0 | 0 | 0 |
| Total current liabilities | 3 | 3 | 7 | 9 | 5 | 6 |
| Total liabilities | 8 | 13 | 12 | 17 | 12 | 12 |
| Shareholders' equity | 39 | 27 | 34 | 63 | 57 | 53 |
| Non-controlling interests and other (assets − liabilities − equity) | 2 | 5 | — | — | — | — |
| Shares outstanding | 16m | 16m | 16m | 22m | 22m | 22m |
Compare with peers
- Keros Therapeutics, Inc. balance sheet
- Alector, Inc. balance sheet
- Lineage Cell Therapeutics, Inc. balance sheet
- Proqr Therapeutics N.V. balance sheet
- Cytomx Therapeutics, Inc. balance sheet
Head to head: ACOG vs KROSACOG vs ALECACOG vs LCTX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies